RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects

Journal of Rheumatology

Volumn 40, Issue 5, 2013, Pages 684-694

  Corrado, Addolorata ^a   Neve, Anna ^a   Macchiarola, Antonio ^b   Gaudio, Annamaria ^a   Marucci, Arcangela ^a   Cantatore, Francesco Paolo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Ospedali Riuniti di Foggia   (Italy)

Author keywords

Osteoarthritis; Osteoblasts; Osteoporosis; Wnt signaling RANKL OPG

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; CALCITRIOL; CELL PROTEIN; COLECALCIFEROL; DICKKOPF 1 PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN DKK 2; UNCLASSIFIED DRUG; VITAMIN D; WNT PROTEIN;

ADULT; AGED; ARTICLE; BONE REMODELING; CELL ACTIVITY; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOARTHRITIS; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VITAMIN BLOOD LEVEL;

OSTEOARTHRITIS; OSTEOBLASTS; OSTEOPOROSIS; RANKL/OPG; WNT SIGNALING;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE RESORPTION; CELL PROLIFERATION; CELLS, CULTURED; CHOLECALCIFEROL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; RANK LIGAND; WNT SIGNALING PATHWAY;

EID: 84875491436     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120845     Document Type: Article

References (37)

1. Radin EL, Paul IL, Tolkoff MJ. Subchondral changes in patients with early degenerative joint disease. Arthritis Rheum 1993;13:400-5.
2. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986;213:34.
3. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 1998;6:374-6. (Pubitemid 28529793)
4. Rechtman AM, Yarrow MW. Osteoporosis. Am Pract Dig Treat 1954;5:691-6.
5. de Seze S, Renier JC, Rakic M. Arthrose vertebrale et osteoporose. Frequences comparees de l'arthrose discovertebrale chez deux groupes de sujets d'age comparable: Osteoporotiques et non osteoporotiques [Vertebral arthrosis and osteoporosis. Comparative incidence of discovertebral arthrosis in 2 groups of subjects of comparable age: Osteoporotics and non-osteoporotics.] Rev Rhum Mal Osteoartic 1962;29:237-43.
6. Healy HJ, Vigorita VJ, Lane JM. The coexistence and characteristics of osteoarthritis and osteoporosis. J Bone Joint Surg 1985;67:586-92. (Pubitemid 15077727)
7. Dequeker J, Boonen S, Aerssens J, Westhovens R. Inverse relationship osteoarthritis-osteoporosis: What is the evidence? What are the consequences? Br J Rheumatol 1996;35:813-20.
8. Cumming RG, Klinerberg RJ. Epidemiological study of the relationship between arthritis of the hip and hip fractures. Ann Rheum Dis 1993;52:707-10. (Pubitemid 23317567)
9. Cantatore FP, Corrado A, Grano M, Quarta L, Colucci S, Melillo N. Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after Vitamin D3 stimulation. Clin Rheumatol 2004;23:490-5. (Pubitemid 39562253)
10. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis. Arthritis Rheum 1998;41:891-9. (Pubitemid 28225790)
11. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1997;40:1282-91. (Pubitemid 27430140)
12. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76. (Pubitemid 28180851)
13. Simonet WS, Lacey DL, Dunstan CR, Kelley MJ, Chang MS, Luthy R, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-19. (Pubitemid 27199902)
14. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004;292:490-5. (Pubitemid 38988958)
15. Butler JS, Murray DW, Hurson CJ, O'Brien J, Doran PP, O'Byrne JM. The role of Dkk-1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density. J Orthop Res 2011;28:414-8.
16. Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, et al. Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005;8:751-64. (Pubitemid 40585297)
17. Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009;60:1438-50.
18. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996;3:312-24. (Pubitemid 26076381)
19. Im GI, Qureshi SA, Kenney J, Rubash H, Shanbhag A. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004;25:4105-15. (Pubitemid 38388576)
20. Westendorf JJ, Kahler RA, Schroeder TN. Wnt signaling in osteoblasts and bone diseases. Gene 2004;341:19-39. (Pubitemid 39335880)
21. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: Novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 2004;318:259-64. (Pubitemid 38526274)
22. Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci USA 2004;101:9757-62. (Pubitemid 38869309)
23. Velasco J, Zarrabeitia MT, Prieto JR, Perez-Castrillon JR, Perez-Aguilar MD, Peren-Nuñez MI, et al. Wnt pathway genes in osteoporosis and osteoarthritis: Differential expression and genetic association study. Osteoporos Int 2010;21:109-18.
24. Dell'Accio F, De Bari C, Eltawil NM, Vanhummein P, Pitzalis C. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signalling after injury and in osteoarthritis. Arthritis Rheum 2008;8:1410-21. (Pubitemid 351705930)
25. Bloom AB, Brockbank SM, van Lent PL, Van Beunigen HM, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009;60:501-12.
26. Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 2007;56:3319-25. (Pubitemid 47585426)
27. Honsawek S, Tanavalee A, Yuktanandana P, Ngarmukos S, Saetan N, Tantavisut S. Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC Musculoskelet Disord 2010;11:257.
28. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63.
29. Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008;26:295-304. (Pubitemid 351659137)
30. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998;139:4743-6. (Pubitemid 28487795)
31. Zhang D, Yang YQ, Li XT, Fu MK. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1-alpha,25-dihydroxyvitamin D3. Arch Oral Biol 2004;49:71-6. (Pubitemid 38161742)
32. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 2007;40:1517-28. (Pubitemid 46756427)
33. Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. J Cell Physiol 2005;203:573-82. (Pubitemid 40629020)
34. Abdallah BM, Stilgren LS, Nissen N, Kassem M, Jorgensen HR, Abrahamsen B. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif Tissue Int 2005;76:90-7. (Pubitemid 40684955)
35. Logar DB, Komadina R, Prezelj J, Ostanek B, Trost Z, Marc J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab 2007;25:219-25. (Pubitemid 47012479)
36. Giner M, Rios MJ, Montoya MG, Vazquez MA, Naji L, Pérez-Cano R. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J Ster Biochem Mol Biol 2009;113:46-51.
37. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM. The ratio of messenger RNA levels of receptor activator of nuclear factor kappa-B ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 2001;16:1015-27. (Pubitemid 32467145)